Toll Free: 1-888-928-9744

Cholestasis Global Clinical Trials Review, H1, 2016

Published: Mar 11, 2016 | Pages: 82 | Publisher: GlobalData | Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Cholestasis Global Clinical Trials Review, H1, 2016

Summary

GlobalData's clinical trial report, "Cholestasis Global Clinical Trials Review, H1, 2016" provides an overview of Cholestasis clinical trials scenario. This report provides top line data relating to the clinical trials on Cholestasis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process. 

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons To Buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
 Table of Contents
Table of Contents 2 List of Tables 3 List of Figures 4 Report Guidance 5 Clinical Trials by Region 6 Clinical Trials and Average Enrollment by Country 7 Top Countries Contributing to Clinical Trials in Asia-Pacific 9 Top Five Countries Contributing to Clinical Trials in Europe 10 Top Countries Contributing to Clinical Trials in North America 11 Top Countries Contributing to Clinical Trials in Middle East and Africa 12 Clinical Trials by G7 Countries: Proportion of Cholestasis to Gastrointestinal Clinical Trials 13 Clinical Trials by Phase in G7 Countries 14 Clinical Trials in G7 Countries by Trial Status 15 Clinical Trials by E7 Countries: Proportion of Cholestasis to Gastrointestinal Clinical Trials 16 Clinical Trials by Phase in E7 Countries 17 Clinical Trials in E7 Countries by Trial Status 18 Clinical Trials by Phase 19 In Progress Trials by Phase 20 Clinical Trials by Trial Status 21 Clinical Trials by End Point Status 22 Subjects Recruited Over a Period of Time 23 Clinical Trials by Sponsor Type 24 Prominent Sponsors 25 Top Companies Participating in Cholestasis Therapeutics Clinical Trials 26 Prominent Drugs 28 Clinical Trial Profile Snapshots 29 Appendix 79 Abbreviations 79 Definitions 79 Research Methodology 80 Secondary Research 80 About GlobalData 81 Contact Us 81 Disclaimer 81 Source 82
List of Tables
Cholestasis Therapeutics, Global, Clinical Trials by Region, 2016* 6 Cholestasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7 Cholestasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8 Cholestasis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2016* 9 Cholestasis Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10 Cholestasis Therapeutics Clinical Trials, North America, Top Countries, 2016* 11 Cholestasis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 12 Proportion of Cholestasis to Gastrointestinal Clinical Trials, G7 Countries (%), 2016* 13 Cholestasis Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 14 Cholestasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 15 Proportion of Cholestasis to Gastrointestinal Clinical Trials, E7 Countries (%), 2016* 16 Cholestasis Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 17 Cholestasis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 18 Cholestasis Therapeutics, Global, Clinical Trials by Phase, 2016* 19 Cholestasis Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 20 Cholestasis Therapeutics, Global, Clinical Trials by Trial Status, 2016* 21 Cholestasis Therapeutics Clinical Trials, Global, by End Point Status, 2016* 22 Cholestasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 23 Cholestasis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 24 Cholestasis Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 25 Cholestasis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27 Cholestasis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28


List of Figures
Cholestasis Therapeutics, Global, Clinical Trials by Region (%), 2016* 6 Cholestasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7 Cholestasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8 Cholestasis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2016* 9 Cholestasis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10 Cholestasis Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11 Proportion of Cholestasis to Gastrointestinal Clinical Trials, G7 Countries (%), 2016* 13 Cholestasis Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 14 Cholestasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 15 Proportion of Cholestasis to Gastrointestinal Clinical Trials, E7 Countries (%), 2016* 16 Cholestasis Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 17 Cholestasis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 18 Cholestasis Therapeutics, Global, Clinical Trials by Phase (%), 2016* 19 Cholestasis Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 20 Cholestasis Therapeutics, Global, Clinical Trials by Trial Status, 2016* 21 Cholestasis Therapeutics Clinical Trials, Global, by End Point Status, 2016* 22 Cholestasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 23 Cholestasis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 24 Cholestasis Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 25 Cholestasis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 26 Cholestasis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28 GlobalData Methodology 80

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global data center UPS market size is estimated to reach USD 5.7 billion by 2020, as per a new research report by Radiant Insights, Inc. Declining tolerance levels pertaining to data loss along with amplifying acceptance of cloud computing is likely

Read More...

Global air traffic control equipment market is projected to reach USD 4.2 billion by 2020, as per a new research report by Radiant Insights, Inc. Mounting price sensitivity among customers with introduction of low fare airlines is expected to drive t

Read More...

Global FPGA market is anticipated to be valued at USD 9,882.5 million by 2020, as per a new research report by Radiant Insights, Inc. Increasing demand for customized IC’s is expected to drive the demand. Customized IC’s helps manufacturers to mo

Read More...

Global aerosol propellants market is anticipated to reach USD 24.8 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing popularity of personal care and cosmetics products such as hair sprays, deodorants and shaving cream

Read More...

Global automotive electronics market size forecast is likely to reach USD 279.96 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing application scope of these equipments is estimated to drive industry growth. Increasing i

Read More...
Choose License Type
Single User - US $2500
Multi User - US $5000
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify